Advanced Medical Solutions Group plc (AIM: AMS)

Market Cap	502.84M
Revenue (ttm)	126.21M
Net Income (ttm)	15.89M
Shares Out	217.68M
EPS (ttm)	0.07
PE Ratio	31.86
Forward PE	21.68
Dividend	0.02 (1.02%)
Ex-Dividend Date	May 30, 2024

Volume	190,706
Open	230.00
Previous Close	231.00
Day's Range	227.72 - 230.86
52-Week Range	171.60 - 255.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 18, 2024

About AMS

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The company offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G brand names. It also provides wound car...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Employees: 850
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: AMS

Financial Performance

In 2023, AMS's revenue was 126.21 million, an increase of 1.51% compared to the previous year's 124.33 million. Earnings were 15.89 million, a decrease of -22.14%.